Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D.

Proc Natl Acad Sci U S A

Cardiovascular Research Institute and Department of Pediatrics, University of California, San Francisco, CA 94118-1245, USA.

Published: September 1998

AI Article Synopsis

Article Abstract

Surfactant protein D (SP-D) is one of two collectins found in the pulmonary alveolus. On the basis of homology with other collectins, potential functions for SP-D include roles in innate immunity and surfactant metabolism. The SP-D gene was disrupted in embryonic stem cells by homologous recombination to generate mice deficient in SP-D. Mice heterozygous for the mutant SP-D allele had SP-D concentrations that were approximately 50% wild type but no other obvious phenotypic abnormality. Mice totally deficient in SP-D were healthy to 7 months but had a progressive accumulation of surfactant lipids, SP-A, and SP-B in the alveolar space. By 8 weeks the alveolar phospholipid pool was 8-fold higher than wild-type littermates. There was also a 10-fold accumulation of alveolar macrophages in the null mice, and many macrophages were both multinucleated and foamy in appearance. Type II cells in the null mice were hyperplastic and contained giant lamellar bodies. These alterations in surfactant homeostasis were not associated with detectable changes in surfactant surface activity, postnatal respiratory function, or survival. The findings in the SP-D-deficient mice suggest a role for SP-D in surfactant homeostasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC21732PMC
http://dx.doi.org/10.1073/pnas.95.20.11869DOI Listing

Publication Analysis

Top Keywords

surfactant homeostasis
12
surfactant protein
8
sp-d
8
deficient sp-d
8
null mice
8
mice
7
surfactant
7
altered surfactant
4
alveolar
4
homeostasis alveolar
4

Similar Publications

Preparation of dried nanoemulsion formulation by electrospinning.

Eur J Pharm Sci

January 2025

University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia. Electronic address:

Dry eye disease is a multifactorial condition characterized by a loss of homeostasis of the tear film. Among the various treatment approaches, the application of ophthalmic oil-in-water nanoemulsions with incorporated anti-inflammatory drugs represents one of the most advanced approaches. However, the liquid nature of nanoemulsions limits their retention time at the ocular surface.

View Article and Find Full Text PDF

Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by excessive accumulation of surfactant components in alveolar macrophages, alveoli, and peripheral airways. The accumulation of surfactant is associated with only a minimal inflammatory response but can lead to the development of pulmonary fibrosis. Three clinical forms of PAP are distinguished - primary, secondary and congenital.

View Article and Find Full Text PDF

Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity.

Front Immunol

January 2025

Department Integrative Agriculture, College of Agriculture and Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.

Surfactant protein D (SP-D) is a C-type lectin that was originally discovered as a lung surfactant associated phospholipid recognising protein. It was originally shown to be of great importance in surfactant turnover and homeostasis in conjunction with another hydrophilic surfactant protein i.e.

View Article and Find Full Text PDF

ConspectusSynthetic extracellular matrix (ECM) engineering is a highly interdisciplinary field integrating materials and polymer science and engineering, chemistry, cell biology, and medicine to develop innovative strategies to investigate and control cell-matrix interactions. Cellular microenvironments are complex and highly dynamic, changing in response to injury and disease. To capture some of these critical dynamics , biomaterial matrices have been developed with tailorable properties that can be modulated in the presence of cells.

View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary alveolar proteinosis (PAP) is a lung disease involving the buildup of lipoprotein material in alveoli due to surfactant issues, with whole lung lavage (WLL) being the main treatment since the 1960s.
  • Autoimmune PAP, the most common type, results from antibodies affecting a crucial growth factor; however, there are currently no international treatment guidelines, and therapeutic strategies depend on PAP type and severity.
  • Although WLL techniques have progressed, a standardized protocol is lacking, making careful planning and patient evaluation critical for successful treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!